
CAS 162704-20-3
:Fórmula:C23H24N2O7S
InChI:InChI=1S/C23H24N2O7S/c1-22(2)23(3,28)21(31-19-10-11-20(27)25(4)24-19)17-13-16(8-9-18(17)32-22)33(29,30)15-7-5-6-14(26)12-15/h5-13,21,26,28H,1-4H3/t21-,23+/m1/s1
Chave InChI:MOZBVDKKWDXRGH-GGAORHGYSA-N
SMILES:C[C@@]1([C@@H](C2=C(C=CC(=C2)S(=O)(=O)C3=CC=CC(=C3)O)OC1(C)C)OC4=NN(C(=O)C=C4)C)O
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 2 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
6-[[(3S,4R)-3-Hydroxy-6-(3-hydroxyphenyl)sulfonyl-2,2,3-trimethyl-4H-chromen-4-yl]oxy]-2-methylpyridazin-3-one
CAS:6-[[(3S,4R)-3-Hydroxy-6-(3-hydroxyphenyl)sulfonyl-2,2,3-trimethyl-4H-chromen-4-yl]oxy]-2-methylpyridazin-3-one is a drug that is metabolized through glucuronidation. It has been shown to be water soluble and stable in the presence of sebaceous glands and follicles. The drug is transported by glycocholate and stabilizes the surface of the skin by binding to its lipids. 6-[(3S,4R)-3-Hydroxy -6-(3hydroxyphenyl)sulfonyl -2,2, 3 trimethyl 4H chromen 4 yl]oxy - 2 methylpyridazin - 3 one also binds to the dermis. This drug interacts with other drugs that have a similar chemical structure (i.eFórmula:C23H24N2O7SPureza:Min. 95%Peso molecular:472.5 g/molUK-157147
CAS:UK-157147 is a substrate for UGT1A1(Km: 105 μM).Fórmula:C23H24N2O7SPureza:98%Cor e Forma:SolidPeso molecular:472.51

